BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mocchi M, Dotti S, Bue MD, Villa R, Bari E, Perteghella S, Torre ML, Grolli S. Veterinary Regenerative Medicine for Musculoskeletal Disorders: Can Mesenchymal Stem/Stromal Cells and Their Secretome Be the New Frontier? Cells 2020;9:E1453. [PMID: 32545382 DOI: 10.3390/cells9061453] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Brondeel C, Pauwelyn G, de Bakker E, Saunders J, Samoy Y, Spaas JH. Review: Mesenchymal Stem Cell Therapy in Canine Osteoarthritis Research: "Experientia Docet" (Experience Will Teach Us). Front Vet Sci 2021;8:668881. [PMID: 34095280 DOI: 10.3389/fvets.2021.668881] [Reference Citation Analysis]
2 Diomaiuto E, Principe V, De Luca A, Laperuta F, Alterisio C, Di Loria A. Exosomes in Dogs and Cats: An Innovative Approach to Neoplastic and Non-Neoplastic Diseases. Pharmaceuticals (Basel) 2021;14:766. [PMID: 34451863 DOI: 10.3390/ph14080766] [Reference Citation Analysis]
3 Villatoro AJ, Martín-Astorga MDC, Alcoholado C, Sánchez-Martín MDM, Becerra J. Proteomic Analysis of the Secretome and Exosomes of Feline Adipose-Derived Mesenchymal Stem Cells. Animals (Basel) 2021;11:295. [PMID: 33498940 DOI: 10.3390/ani11020295] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Mocchi M, Bari E, Dotti S, Villa R, Berni P, Conti V, Del Bue M, Squassino GP, Segale L, Ramoni R, Torre ML, Perteghella S, Grolli S. Canine Mesenchymal Cell Lyosecretome Production and Safety Evaluation after Allogenic Intraarticular Injection in Osteoarthritic Dogs. Animals (Basel) 2021;11:3271. [PMID: 34828003 DOI: 10.3390/ani11113271] [Reference Citation Analysis]
5 Mocchi M, Grolli S, Dotti S, Di Silvestre D, Villa R, Berni P, Conti V, Passignani G, Brambilla F, Bue MD, Catenacci L, Sorrenti M, Segale L, Bari E, Mauri P, Torre ML, Perteghella S. Equine Mesenchymal Stem/Stromal Cells Freeze-Dried Secretome (Lyosecretome) for the Treatment of Musculoskeletal Diseases: Production Process Validation and Batch Release Test for Clinical Use. Pharmaceuticals (Basel) 2021;14:553. [PMID: 34200627 DOI: 10.3390/ph14060553] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Ribitsch I, Oreff GL, Jenner F. Regenerative Medicine for Equine Musculoskeletal Diseases. Animals (Basel) 2021;11:234. [PMID: 33477808 DOI: 10.3390/ani11010234] [Reference Citation Analysis]
7 Gan QF, Foo CN, Leong PP, Cheong SK. Incorporating regenerative medicine into rehabilitation programmes: a potential treatment for ankle sprain. International Journal of Therapy and Rehabilitation 2021;28:1-15. [DOI: 10.12968/ijtr.2019.0119] [Reference Citation Analysis]
8 Pye C, Bruniges N, Peffers M, Comerford E. Advances in the pharmaceutical treatment options for canine osteoarthritis. J of Small Animal Practice. [DOI: 10.1111/jsap.13495] [Reference Citation Analysis]
9 Lu L, Xu A, Gao F, Tian C, Wang H, Zhang J, Xie Y, Liu P, Liu S, Yang C, Ye Z, Wu X. Mesenchymal Stem Cell-Derived Exosomes as a Novel Strategy for the Treatment of Intervertebral Disc Degeneration. Front Cell Dev Biol 2022;9:770510. [DOI: 10.3389/fcell.2021.770510] [Reference Citation Analysis]